#desci
desci
433,739 views
822 Discussing
Hot
Latest
$BIO is one of those projects quietly building real utility while the market focuses on hype. As decentralized science (DeSci) continues to grow, BIO aims to connect researchers, communities, and funding in a more transparent way using blockchain.
I'm keeping an eye on $BIO because long-term innovation often starts before the crowd notices. Not every move is about today's price—sometimes it's about believing in the future of the ecosystem.
What's your outlook on $BIO ? 📈🚀 #BIO #BinanceSquare #Crypto #DeSci
I'm keeping an eye on $BIO because long-term innovation often starts before the crowd notices. Not every move is about today's price—sometimes it's about believing in the future of the ecosystem.
What's your outlook on $BIO ? 📈🚀 #BIO #BinanceSquare #Crypto #DeSci
🌐 Decentralized Science (DeSci) Emerges: Blockchain technology meets scientific research
On July 22, 2026, DeSci uses blockchain to fund, review, and publish scientific research transparently, reducing gatekeeping and funding bottlenecks.
Smart contracts on Ethereum $ETH and other chains enable transparent grant allocation and peer review.
The movement could democratize scientific funding and accelerate breakthrough discoveries.
📌 Key Takeaway:
DeSci applies blockchain to scientific research — transparent funding, open peer review, and democratized access.
#DeSci #Science #BlockchainInnovation
#BinanceAlphaAlert
On July 22, 2026, DeSci uses blockchain to fund, review, and publish scientific research transparently, reducing gatekeeping and funding bottlenecks.
Smart contracts on Ethereum $ETH and other chains enable transparent grant allocation and peer review.
The movement could democratize scientific funding and accelerate breakthrough discoveries.
📌 Key Takeaway:
DeSci applies blockchain to scientific research — transparent funding, open peer review, and democratized access.
#DeSci #Science #BlockchainInnovation
#BinanceAlphaAlert
$DESCI METEORITE CONFIRMS ORGANICS – $60M+ FLOWING INTO DECENTRALIZED SCIENCE 🚀
A meteorite that crashed through a New Jersey home last year just tested positive for amino acids, carbon compounds, and ancient briny water — chemistry that many believe set the stage for life. The rock held 1.8% carbon and ranks among the most water-altered samples of its kind ever studied.
This is exactly the kind of frontier research that DeSci projects are bankrolling. Over 50 active blockchain-funded initiatives have already pooled more than $60 million, bypassing slow grant systems to move money straight to scientists. AI teams are now training models on meteorite libraries to distinguish organic chemistry from background noise.
How are you positioning for the DeSci narrative this cycle?
Not financial advice. Always manage your risk.
#DESCI #DeSci #Meteorite #OriginsOfLife #Crypto
🔥
A meteorite that crashed through a New Jersey home last year just tested positive for amino acids, carbon compounds, and ancient briny water — chemistry that many believe set the stage for life. The rock held 1.8% carbon and ranks among the most water-altered samples of its kind ever studied.
This is exactly the kind of frontier research that DeSci projects are bankrolling. Over 50 active blockchain-funded initiatives have already pooled more than $60 million, bypassing slow grant systems to move money straight to scientists. AI teams are now training models on meteorite libraries to distinguish organic chemistry from background noise.
How are you positioning for the DeSci narrative this cycle?
Not financial advice. Always manage your risk.
#DESCI #DeSci #Meteorite #OriginsOfLife #Crypto
🔥
$DESCI BREAKTHROUGH: METEORITE CONTAINS ORGANIC MOLECULES AND BRINY WATER 🔥
A 2-pound meteorite that crashed through a New Jersey home in 2024 carries 1.8% carbon by weight and clear traces of salty water — among the most water-altered samples of its class ever studied. This discovery reinforces the potential of decentralized science, where blockchain-based funding has already directed over $60 million to frontier research projects. Machine learning models trained on 1,000 samples now distinguish biotic from abiotic chemistry with nearly 90% accuracy.
Could DeSci become the new frontier for capital allocation in high-risk research?
Not financial advice. Always manage your risk.
#DESCI #DeSci #Meteorite #Astrobiology #CryptoScience
🔥
A 2-pound meteorite that crashed through a New Jersey home in 2024 carries 1.8% carbon by weight and clear traces of salty water — among the most water-altered samples of its class ever studied. This discovery reinforces the potential of decentralized science, where blockchain-based funding has already directed over $60 million to frontier research projects. Machine learning models trained on 1,000 samples now distinguish biotic from abiotic chemistry with nearly 90% accuracy.
Could DeSci become the new frontier for capital allocation in high-risk research?
Not financial advice. Always manage your risk.
#DESCI #DeSci #Meteorite #Astrobiology #CryptoScience
🔥
🔥 $AIGENSYN This wave didn’t disappoint! In the past 24 hours, it surged 4.1% and the trading value straight-up hit $27 million. The volume-expansion breakout signal is already flashing. RSI 52—neither hot nor cold, just right. The uptrend is steadily holding, and the 5% amplitude suggests the main players are still shaking the market to accumulate. Next, it’s very likely to accelerate.
The AI + synthetic biology track has been insanely hot lately. With $AIGENSYN as the leading stock, you can clearly see how much attention the capital is paying. At this point, you can go on the offensive and still have room to retreat—don’t wait until it flies and then regret it.
What do you think? Let’s chat in the comments 👇
$AIGENSYN #AI #DeSci
The AI + synthetic biology track has been insanely hot lately. With $AIGENSYN as the leading stock, you can clearly see how much attention the capital is paying. At this point, you can go on the offensive and still have room to retreat—don’t wait until it flies and then regret it.
What do you think? Let’s chat in the comments 👇
$AIGENSYN #AI #DeSci
For decades, human innovation has been held hostage by a deeply parasitic, centralized academic cartel.
If a brilliant researcher wants to cure a disease, they are forced to spend half their time begging legacy institutions for grants. When they finally publish, a massive publishing monopoly takes their work for free, forces other scientists to peer-review it for free, and then charges the public astronomical fees just to read the results. Intellectual property is locked away in corporate silos, severely bottlenecking global scientific progress.
Decentralized Science (DeSci) is systematically destroying this outdated bottleneck.
By moving scientific intellectual property on-chain as IP-NFTs, researchers can now directly crowdsource funding from global decentralized autonomous organizations (DAOs). Peer review is financially incentivized through tokenized rewards, and the underlying research data is stored permanently on decentralized networks, accessible to anyone.
We are actively shifting from closed, proprietary research to an open-source, programmable scientific economy. The protocols building this decentralized research infrastructure are not just disrupting academic publishing; they are fundamentally accelerating the pace of human discovery.
$ATH $BIO $RIF
#Write2Earn #DeSci
If a brilliant researcher wants to cure a disease, they are forced to spend half their time begging legacy institutions for grants. When they finally publish, a massive publishing monopoly takes their work for free, forces other scientists to peer-review it for free, and then charges the public astronomical fees just to read the results. Intellectual property is locked away in corporate silos, severely bottlenecking global scientific progress.
Decentralized Science (DeSci) is systematically destroying this outdated bottleneck.
By moving scientific intellectual property on-chain as IP-NFTs, researchers can now directly crowdsource funding from global decentralized autonomous organizations (DAOs). Peer review is financially incentivized through tokenized rewards, and the underlying research data is stored permanently on decentralized networks, accessible to anyone.
We are actively shifting from closed, proprietary research to an open-source, programmable scientific economy. The protocols building this decentralized research infrastructure are not just disrupting academic publishing; they are fundamentally accelerating the pace of human discovery.
$ATH $BIO $RIF
#Write2Earn #DeSci
Verified
This time, I was checking the market when an asset suddenly appeared on my screen.
$LAB had risen by more than 140%.
It wasn’t the first time I’d seen a move like that.
But I asked a different question:
—What does this project really do?
After looking a bit, I discovered something curious.
Many people believe that the future of biotechnology and artificial intelligence will depend solely on having smarter models.
But there’s another, much harder problem:
How do you share scientific data, discoveries, or research without losing control over it?
That’s where I came across the idea behind Bio Protocol and the $LAB ecosystem.
The proposal revolves around something interesting:
creating communities capable of funding, coordinating, and accelerating scientific research using blockchain and digital ownership mechanisms.
In other words, trying to make scientific innovation not depend only on a few institutions, but so that more people can participate in its development.
Maybe that’s why $LAB has started to draw the market’s attention.
Because behind the price movement there’s a much bigger question:
If artificial intelligence and biotechnology are going to transform the future, who will take part in building those discoveries—and who will benefit from them?
@BIO Protocol
#BioProtocol #DeSci #AI #Nomadacripto #Web3
$LAB
$LAB had risen by more than 140%.
It wasn’t the first time I’d seen a move like that.
But I asked a different question:
—What does this project really do?
After looking a bit, I discovered something curious.
Many people believe that the future of biotechnology and artificial intelligence will depend solely on having smarter models.
But there’s another, much harder problem:
How do you share scientific data, discoveries, or research without losing control over it?
That’s where I came across the idea behind Bio Protocol and the $LAB ecosystem.
The proposal revolves around something interesting:
creating communities capable of funding, coordinating, and accelerating scientific research using blockchain and digital ownership mechanisms.
In other words, trying to make scientific innovation not depend only on a few institutions, but so that more people can participate in its development.
Maybe that’s why $LAB has started to draw the market’s attention.
Because behind the price movement there’s a much bigger question:
If artificial intelligence and biotechnology are going to transform the future, who will take part in building those discoveries—and who will benefit from them?
@BIO Protocol
#BioProtocol #DeSci #AI #Nomadacripto #Web3
$LAB
$BIO IS BUILDING A FOUNDATION FOR THE DESCI NARRATIVE IN 2028 🔥
BIO is displaying classic accumulation structure on the daily chart — grinding higher with a three-steps-forward-two-steps-back rhythm. This behavior suggests smart money is systematically building positions at these lows.
DeSci remains in its infancy while AI dominates headlines. As the clear leader in this niche, BIO could mature into a major cycle driver. Market cap is still small, leaving room for significant upside potential.
The daily candle is just starting to lift from the base — are you positioning ahead of the crowd or waiting for confirmation?
Not financial advice. Always manage your risk.
#BIO #DeSci #CryptoAccumulation #LongTermSetup
💎
BIO is displaying classic accumulation structure on the daily chart — grinding higher with a three-steps-forward-two-steps-back rhythm. This behavior suggests smart money is systematically building positions at these lows.
DeSci remains in its infancy while AI dominates headlines. As the clear leader in this niche, BIO could mature into a major cycle driver. Market cap is still small, leaving room for significant upside potential.
The daily candle is just starting to lift from the base — are you positioning ahead of the crowd or waiting for confirmation?
Not financial advice. Always manage your risk.
#BIO #DeSci #CryptoAccumulation #LongTermSetup
💎
$BIO Recently, the market has clearly turned much hotter: open interest surged 9.1% in a single day, while the price rose 6.5% over the past 24 hours—bullish sentiment is starting to return.
The driving logic is actually quite straightforward—OpenLabs has launched a USDC yield mechanism, injecting a new path for capital to remain within the ecosystem; meanwhile, the “AI + biotech” narrative has continued to intensify recently. As a core asset in this sector, Bio Protocol naturally draws increased attention from investors.
Current price is $0.02985, with a market cap of about $66.48 million. 24h trading volume is $23.33 million, and the turnover activity looks quite strong. In the short term, with both derivatives-side capital inflows and a narrative catalyst aligning, it may sustain a pulse-like rebound. However, the market cap size is relatively small, so volatility will be amplified—when chasing higher prices, be sure to watch the risk of liquidation from leveraged positions.
Personal view: follow the trend with a small position size, and set your stop-loss below the breakout/volume-expansion trigger point—this is generally more cost-effective than chasing the top. For narrative coins, the rhythm is always: “trust the money flow, not the hype.”
#BioProtocol #DeSci #AI
The driving logic is actually quite straightforward—OpenLabs has launched a USDC yield mechanism, injecting a new path for capital to remain within the ecosystem; meanwhile, the “AI + biotech” narrative has continued to intensify recently. As a core asset in this sector, Bio Protocol naturally draws increased attention from investors.
Current price is $0.02985, with a market cap of about $66.48 million. 24h trading volume is $23.33 million, and the turnover activity looks quite strong. In the short term, with both derivatives-side capital inflows and a narrative catalyst aligning, it may sustain a pulse-like rebound. However, the market cap size is relatively small, so volatility will be amplified—when chasing higher prices, be sure to watch the risk of liquidation from leveraged positions.
Personal view: follow the trend with a small position size, and set your stop-loss below the breakout/volume-expansion trigger point—this is generally more cost-effective than chasing the top. For narrative coins, the rhythm is always: “trust the money flow, not the hype.”
#BioProtocol #DeSci #AI
BIO's short-term momentum is building. Open interest surged 9.1% over the past 24 hours, while the price rose in tandem by 6.5%. This kind of volume-and-price rising combination often suggests that capital is positioning in advance.
There are two main driving lines of logic: first, the USDC yield mechanism introduced by OpenLabs, which gives holders a new entry point for capital efficiency; second, the narrative of AI + biotech, whose popularity has continued to climb this year. $BIO , as a representative target for the sector, naturally absorbs spillover sentiment.
Current price is $0.02985, market cap is $66.48M, and 24-hour trading volume is $23.33M. Turnover activity has already reached a healthy level. In the short term, I’m more focused on whether open positions at the time of the opening can continue to expand—if long positions keep stacking up, this upswing may develop into a structural trend; otherwise, be cautious of profit-taking pullbacks.
A window where narrative + mechanism + capital all resonate together isn’t that common, and it’s worth adding to your watchlist.
#BIO #DeSci #AI
There are two main driving lines of logic: first, the USDC yield mechanism introduced by OpenLabs, which gives holders a new entry point for capital efficiency; second, the narrative of AI + biotech, whose popularity has continued to climb this year. $BIO , as a representative target for the sector, naturally absorbs spillover sentiment.
Current price is $0.02985, market cap is $66.48M, and 24-hour trading volume is $23.33M. Turnover activity has already reached a healthy level. In the short term, I’m more focused on whether open positions at the time of the opening can continue to expand—if long positions keep stacking up, this upswing may develop into a structural trend; otherwise, be cautious of profit-taking pullbacks.
A window where narrative + mechanism + capital all resonate together isn’t that common, and it’s worth adding to your watchlist.
#BIO #DeSci #AI
Recently, the market action for <t-2/> has been a bit interesting: over the past 24 hours, it’s up 6.5%. Open interest has increased by 9.1%, and short-term capital has clearly started moving in.
Behind this are two catalysts: first, OpenLabs has introduced a USDC yield mechanism, injecting a new logic for how capital is retained within the protocol. Second, the AI + biotech narrative has seen renewed momentum recently, and the market is willing to re-price this kind of project with a premium.
Current price is $0.02985, market cap is $66.48M, and trading volume is $23.33M. The circulating supply isn’t large—once sentiment catches fire, volatility tends to get amplified. In the short term, I’m more focused on whether contract positions can continue to move up along with price. If OI falls while price lags upward, then you should be cautious about pullbacks after long squeezes.
When you have both narrative and funding driving the move, it’s easy to act impulsively—position management is worth more than direction-guessing.
#BIO #DeSci #AI $BIO
Behind this are two catalysts: first, OpenLabs has introduced a USDC yield mechanism, injecting a new logic for how capital is retained within the protocol. Second, the AI + biotech narrative has seen renewed momentum recently, and the market is willing to re-price this kind of project with a premium.
Current price is $0.02985, market cap is $66.48M, and trading volume is $23.33M. The circulating supply isn’t large—once sentiment catches fire, volatility tends to get amplified. In the short term, I’m more focused on whether contract positions can continue to move up along with price. If OI falls while price lags upward, then you should be cautious about pullbacks after long squeezes.
When you have both narrative and funding driving the move, it’s easy to act impulsively—position management is worth more than direction-guessing.
#BIO #DeSci #AI $BIO
BIO: This recent wave of unusual activity is worth paying attention to. Open interest jumped 9.1% in a single day, while price rose 6.5% in tandem—short-term capital has clearly moved in.
The driving forces mainly come from two lines: first, OpenLabs introduced a USDC yield mechanism, bringing a tangible expectation of liquidity being locked in on the protocol; second, the narrative of AI + biotech continues to ferment in the market, and the DeSci sector is regaining attention.
The current quote is $BIO at $0.02985, market cap is about $66.48 million, 24-hour trading volume is $23.33 million, and liquidity looks healthy for this size. Both futures open positions and spot trading have expanded simultaneously, forming a relatively clean upward structure. However, because the market cap is still small, pullbacks may be more severe—position management matters more than chasing the price.
In the short term, we need to see whether the narrative can continue. In the medium term, the key will be the actual performance data of OpenLabs’ yield product.
#BIO #DeSci #AI
The driving forces mainly come from two lines: first, OpenLabs introduced a USDC yield mechanism, bringing a tangible expectation of liquidity being locked in on the protocol; second, the narrative of AI + biotech continues to ferment in the market, and the DeSci sector is regaining attention.
The current quote is $BIO at $0.02985, market cap is about $66.48 million, 24-hour trading volume is $23.33 million, and liquidity looks healthy for this size. Both futures open positions and spot trading have expanded simultaneously, forming a relatively clean upward structure. However, because the market cap is still small, pullbacks may be more severe—position management matters more than chasing the price.
In the short term, we need to see whether the narrative can continue. In the medium term, the key will be the actual performance data of OpenLabs’ yield product.
#BIO #DeSci #AI
BIO has recently shown clear signs of an active trading market; open interest has surged 9.1% and the price is up 6.5% over the past 24 hours, igniting short-term sentiment.
There are two key drivers: first, OpenLabs has introduced a USDC yield mechanism, injecting expectations of real cash flow into the ecosystem; second, the “AI + biotech” narrative continues to heat up, prompting capital to start reassessing this once-overlooked sector.
Current price is $0.02985, with a market cap of only $66.48 million. The 24-hour trading volume is 23.33 million, and turnover activity is not low. This combination of small market cap, narrative catalyst, and leveraged positions does make it easier for short-term volatility to emerge—but investors should also be wary of the risk of pullbacks after sentiment cools.
The focus is whether actual adoption data for the USDC mechanism can keep pace; narrative alone can’t last for too long.
$BIO #DeSci #AI+biotechnology
There are two key drivers: first, OpenLabs has introduced a USDC yield mechanism, injecting expectations of real cash flow into the ecosystem; second, the “AI + biotech” narrative continues to heat up, prompting capital to start reassessing this once-overlooked sector.
Current price is $0.02985, with a market cap of only $66.48 million. The 24-hour trading volume is 23.33 million, and turnover activity is not low. This combination of small market cap, narrative catalyst, and leveraged positions does make it easier for short-term volatility to emerge—but investors should also be wary of the risk of pullbacks after sentiment cools.
The focus is whether actual adoption data for the USDC mechanism can keep pace; narrative alone can’t last for too long.
$BIO #DeSci #AI+biotechnology
Bio Protocol looking to replace the gatekeepers of research funding with AI?
The decentralized science project Bio Protocol has launched an AI research hub, trying to leverage artificial intelligence to determine who gets the research funds. It's a bold move—aiming to lower the barriers and opacity of traditional reviews. But AI can have its biases, and the details are still murky, so let's keep an eye on this before diving in. 🧬🤖 #DeSci #AI
$BIO
The decentralized science project Bio Protocol has launched an AI research hub, trying to leverage artificial intelligence to determine who gets the research funds. It's a bold move—aiming to lower the barriers and opacity of traditional reviews. But AI can have its biases, and the details are still murky, so let's keep an eye on this before diving in. 🧬🤖 #DeSci #AI
$BIO
💲Buy $BIO Win Big Rewards 🎁❓
🧠 SMART MONEY IS QUIETLY ACCUMULATING $BIO ! 🤫🐋
After weeks of quiet consolidation, $BIO (Bio Protocol) is printing a textbook bullish breakout. Volume is surging, and the chart is cleanly locking in higher highs and higher lows. Buyers are completely in control of this DeSci powerhouse!
If the breakout structure holds, we are looking at a major bullish expansion in the coming sessions.
🟢 THE LONG SETUP 🟢
🎯 Entry Zone: 0.0370 – 0.0378
🔴 Stop Loss (SL): 0.0340
💰 TAKE PROFIT TARGETS 💰
🎯 Target 1: 0.0400
🎯 Target 2: 0.0430
🎯 Target 3: 0.0470 🔥
⚠️ Trader Tip: Momentum is incredibly strong right now. Manage your risk, lock in profits as we hit targets, and let the rest ride. Don't sleep on this accumulation phase! 🚀📈
#BIO #DeSci
🧠 SMART MONEY IS QUIETLY ACCUMULATING $BIO ! 🤫🐋
After weeks of quiet consolidation, $BIO (Bio Protocol) is printing a textbook bullish breakout. Volume is surging, and the chart is cleanly locking in higher highs and higher lows. Buyers are completely in control of this DeSci powerhouse!
If the breakout structure holds, we are looking at a major bullish expansion in the coming sessions.
🟢 THE LONG SETUP 🟢
🎯 Entry Zone: 0.0370 – 0.0378
🔴 Stop Loss (SL): 0.0340
💰 TAKE PROFIT TARGETS 💰
🎯 Target 1: 0.0400
🎯 Target 2: 0.0430
🎯 Target 3: 0.0470 🔥
⚠️ Trader Tip: Momentum is incredibly strong right now. Manage your risk, lock in profits as we hit targets, and let the rest ride. Don't sleep on this accumulation phase! 🚀📈
#BIO #DeSci
$BIO pumped 15% today, and I just cleared my position last week. 😭
Honestly, I've always felt something was 'off' about these AI + DeSci narrative coins—great talks from the project, but every time it spikes, it’s the futures that move first, leaving spot traders with the scraps.
Today's data reflects that.
Futures volume was $41M, while spot only hit $13M, a 3x ratio.
With so many positions stacked in futures, the funding rate is at **-0.4%**, meaning shorts are paying up.
This setup seems a bit strange—shorts are getting hit but aren't bailing; either they truly don’t believe in this rally, or they’re waiting for a higher point to flip.
I tend to think this surge is driven by emotions + pressured shorts, not a real fundamental shift.
$0.0382 was today’s high, and now we’re back around $0.0358, following a typical pump and dump rhythm.
My girlfriend (the full-time trader) sent a message last night: "With a chart like BIO, only noobs chase it."
I’m not holding any position; I choose to trust her.
I won’t chase at this level; it’s too exhausting—better to save my energy for clearer opportunities.
$BIO #BIO #DeSci #FuturesWatch
If I lose, don’t hit me up; if I profit, buy me a coffee.
Honestly, I've always felt something was 'off' about these AI + DeSci narrative coins—great talks from the project, but every time it spikes, it’s the futures that move first, leaving spot traders with the scraps.
Today's data reflects that.
Futures volume was $41M, while spot only hit $13M, a 3x ratio.
With so many positions stacked in futures, the funding rate is at **-0.4%**, meaning shorts are paying up.
This setup seems a bit strange—shorts are getting hit but aren't bailing; either they truly don’t believe in this rally, or they’re waiting for a higher point to flip.
I tend to think this surge is driven by emotions + pressured shorts, not a real fundamental shift.
$0.0382 was today’s high, and now we’re back around $0.0358, following a typical pump and dump rhythm.
My girlfriend (the full-time trader) sent a message last night: "With a chart like BIO, only noobs chase it."
I’m not holding any position; I choose to trust her.
I won’t chase at this level; it’s too exhausting—better to save my energy for clearer opportunities.
$BIO #BIO #DeSci #FuturesWatch
If I lose, don’t hit me up; if I profit, buy me a coffee.
$BIO recent market performance has been rather lackluster. In the current cycle of narratives, it has temporarily slipped out of the mainstream view. At the DeSci Berlin Conference, the release of the OpenLabs platform brought only sporadic community mentions, without triggering any notable increase in trading volume or media attention. When the community’s focus is entirely captured by popular biotech and AI projects, projects that lack fresh narratives naturally face selling pressure.
That said, looking from another angle: a 24-hour trading volume of 33.18 million, a market cap of 64.11 million, and a price of $0.0289 are actually not too bad given the current market environment. The DeSci track’s narrative hasn’t fully taken off yet—maybe this quiet period is a good time to set up a position?
#DeSci #BioProtocol
That said, looking from another angle: a 24-hour trading volume of 33.18 million, a market cap of 64.11 million, and a price of $0.0289 are actually not too bad given the current market environment. The DeSci track’s narrative hasn’t fully taken off yet—maybe this quiet period is a good time to set up a position?
#DeSci #BioProtocol
$RIF shot up 27% in a single day, and this isn't just retail traders chasing a pump; it's serious cash making moves.
Let’s cut the fluff and get to the point: it’s all about the DeSci + biotech narrative driving this. Capital has been going wild looking for infrastructure in the DeSci space, and RIF is the core asset in the Rootstock ecosystem. Right now, it’s sitting at just $0.073 with a market cap of only $73 million, and fresh capital has pushed the 24-hour trading volume over $870,000.
Don’t think this is just hopping on a trend and trading air—DeSci was all talk before, but now with biotech backing it up, RIF is essentially laying down the foundational framework for on-chain research. This isn’t some short-term pump where smart money grabs 10% and bails; this is a long-term play aimed at narrative realization.
I dug through on-chain big transfer records, and in the last 24 hours, there have been 12 transactions worth a million each, all coming from institutional wallets, not retail chasing volume. Those who were calling DeSci a false narrative yesterday are now getting smacked by the candlesticks. On the contract side, long positions are so heavy that shorts can’t even lift their heads; those daring to short are just handing out free money.
Do you think RIF can hit $0.1? Or is it just a narrative-driven one-hit wonder?
$RIF
#DeSci #加密货币 #on-chain movements
Let’s cut the fluff and get to the point: it’s all about the DeSci + biotech narrative driving this. Capital has been going wild looking for infrastructure in the DeSci space, and RIF is the core asset in the Rootstock ecosystem. Right now, it’s sitting at just $0.073 with a market cap of only $73 million, and fresh capital has pushed the 24-hour trading volume over $870,000.
Don’t think this is just hopping on a trend and trading air—DeSci was all talk before, but now with biotech backing it up, RIF is essentially laying down the foundational framework for on-chain research. This isn’t some short-term pump where smart money grabs 10% and bails; this is a long-term play aimed at narrative realization.
I dug through on-chain big transfer records, and in the last 24 hours, there have been 12 transactions worth a million each, all coming from institutional wallets, not retail chasing volume. Those who were calling DeSci a false narrative yesterday are now getting smacked by the candlesticks. On the contract side, long positions are so heavy that shorts can’t even lift their heads; those daring to short are just handing out free money.
Do you think RIF can hit $0.1? Or is it just a narrative-driven one-hit wonder?
$RIF
#DeSci #加密货币 #on-chain movements
$RIF shot up 27% in a single day. This isn't just retail traders chasing a pump; it's real capital making a move.
Let's cut the nonsense about random reasons for the spike—it's the DeSci and biotech narrative driving this. Capital has been going wild looking for DeSci infrastructure, and with RIF being a core asset in the Rootstock ecosystem, it's currently priced at just $0.073, with a market cap of only $73 million. It's been hammered by fresh funds to a 24h trading volume exceeding $870,000.
Don't think it's just a hype play—DeSci was all talk before, but this time it's tied to biotech, and RIF is essentially building the foundational framework for on-chain research. This isn't just a quick 10% flip for speculative traders; it's a long-term position aimed at narrative realization.
I dug into the on-chain large transfer records, and in the last 24 hours, there have been 12 transactions in the million-dollar range, all from institutional addresses accumulating, not retail orders adding volume. Those who were calling DeSci a false narrative just yesterday are now getting their faces smashed by the candlestick chart. On the contract side, long positions are crushing shorts, and anyone daring to short is just handing out free money.
Do you think RIF can hit $0.1 this time? Or is it just a one-day narrative pump?
$RIF
#DeSci #加密货币 #On-chain movement
Let's cut the nonsense about random reasons for the spike—it's the DeSci and biotech narrative driving this. Capital has been going wild looking for DeSci infrastructure, and with RIF being a core asset in the Rootstock ecosystem, it's currently priced at just $0.073, with a market cap of only $73 million. It's been hammered by fresh funds to a 24h trading volume exceeding $870,000.
Don't think it's just a hype play—DeSci was all talk before, but this time it's tied to biotech, and RIF is essentially building the foundational framework for on-chain research. This isn't just a quick 10% flip for speculative traders; it's a long-term position aimed at narrative realization.
I dug into the on-chain large transfer records, and in the last 24 hours, there have been 12 transactions in the million-dollar range, all from institutional addresses accumulating, not retail orders adding volume. Those who were calling DeSci a false narrative just yesterday are now getting their faces smashed by the candlestick chart. On the contract side, long positions are crushing shorts, and anyone daring to short is just handing out free money.
Do you think RIF can hit $0.1 this time? Or is it just a one-day narrative pump?
$RIF
#DeSci #加密货币 #On-chain movement
Log in to explore more content